טוען...
Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures
OBJECTIVE: Intravenous (IV) levetiracetam (LEV) is approved for use in patients older than 16 years and may be useful in critically ill children, although there is little data available regarding pharmacokinetics. We aim to investigate the safety, an appropriate dosing, and efficacy of IV LEV in cri...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2946960/ https://ncbi.nlm.nih.gov/pubmed/19325512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PCC.0b013e3181a0e1cf |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|